1992 |
Prostate cancer xenograft made from CWR22 sample |
1999 |
New prostate carcinoma cell line 22Rv1 used in labs |
2006 |
XMRV identified in prostate cancer samples |
2008–2011 |
Multiple labs test prostate cancer samples for XMRV |
2009 |
XMRV identified in CFS patient samples |
2010 |
MLV-related sequences identified in CFS patient samples |
2010 |
Multiple labs test CFS samples for XMRV |
2010 |
Food and Drug Administration panel of experts recommends indefinite deferral of blood donors with CFS |
2010–2011 |
Red Cross in multiple countries defers donors with history of or symptoms consistent with CFS |
2011 |
Investigation of XMRV and possible contamination |
2011 |
Article published tracing origin of XMRV to laboratory recombination event |
2012 |
Key XMRV and MLV papers retracted |